A new study shows that enhancing activity of a specific component of ‘NMDA’ receptors normalizes protein synthesis, neural activity and seizure susceptibility in the hippocampus of fragile X lab mice.
Study suggests new molecular strategy for treating fragile X syndrome
- Post author:Annie Holland
- Post published:February 20, 2025
- Post category:News Feed
- Post comments:0 Comments